Reimbursement, Appeals, and Billing and Coding for MONJUVI
Effective April 1, 2021, MONJUVI has been assigned J9349: Injection, tafasitamab-cxix, 2mg. Access these resources and references to help assist with the reimbursement process for MONJUVI.
J-Code Quick Reference Guide (2 MB)
- Product Codes
- Procedure Codes
- National Drug Codes (NDCs)
- Revenue Codes for the physician office setting as well as the hospital outpatient setting
Sample Appeals Letters:
Sample Appeal Letter (63 KB)
MONJUVI Product Ordering Guide (623 KB)
My MISSION Support
Learn about the My MISSION Support Program and the personalized assistance provided.